Influvac sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated) Malta - Inggeris - Medicines Authority

influvac sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated)

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - a, guangdong, maonan, swl, hong kong, b, washington - suspension for injection in pre-filled syringe - a/guangdong-maonan/swl1536/2019 15 µg a/hong kong/2671/2019 15 µg b/washington/02/2019 15 µg - vaccines

Flucelvax Quad Quadrivalent influenza vaccine (surface antigen  inactivated) suspension for injection pre-filled syringe with attached needle Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

flucelvax quad quadrivalent influenza vaccine (surface antigen inactivated) suspension for injection pre-filled syringe with attached needle

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: water for injections; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; magnesium chloride hexahydrate; potassium chloride - for the prevention of influenza caused by influenza virus, types a and b contained in the vaccine. the vaccine is indicated for use in adults and children 6 months of age and older. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.

Respiporc FLUpan H1N1 Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

respiporc flupan h1n1

idt biologika gmbh - inactivated influenza a virus/human - immunologicals, inactivated viral vaccines for pigs, porcine influenza virus - pigs - active immunisation of pigs from the age of 8 weeks onwards against pandemic h1n1 porcine influenza virus to reduce viral lung load and viral excretion.

AGRIPPAL S1 Israel - Inggeris - Ministry of Health

agrippal s1

neopharm scientific ltd - a/brisbane/02/2018(h1n1)pdm09-like virus; a/kansas/14/2017 (h3n2) like virus; b/colorado/06/2017- like virus (b/victoria/2/87 lineage); b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 15 mcg / 0.5 ml; b/colorado/06/2017- like virus (b/victoria/2/87 lineage) 15 mcg / 0.5 ml; a/kansas/14/2017 (h3n2) like virus 15 mcg / 0.5 ml; a/brisbane/02/2018(h1n1)pdm09-like virus 15 mcg / 0.5 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - prophylaxis of influenza.

INFLUVAC suspension for injection 0.5ml Singapura - Inggeris - HSA (Health Sciences Authority)

influvac suspension for injection 0.5ml

abbott laboratories (singapore ) private limited - influenza virus (sh) a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237); influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238); influenza virus (sh) b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - injection, suspension - 15mcg haemagglutinin/0.5ml - influenza virus (sh) a/thailand/8/2022 (h3n2)-like strain (a/thailand/8/2022, ivr-237) 15mcg ha/0.5ml; influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) 15mcg ha/0.5 ml; influenza virus (sh) b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) 15mcg ha/0.5ml